OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
Ning‐Ning Liu, Chengxiang Yi, Luqi Wei, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1927-1944.e9
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Lung microbiome: new insights into the pathogenesis of respiratory diseases
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 112

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 39

Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 297-360
Open Access | Times Cited: 29

Robustness of cancer microbiome signals over a broad range of methodological variation
Gregory D. Sepich‐Poore, Daniel McDonald, Evguenia Kopylova, et al.
Oncogene (2024) Vol. 43, Iss. 15, pp. 1127-1148
Open Access | Times Cited: 23

A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20

Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 18

Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 14

Fungi, immunosenescence and cancer
Bin Xu, Zan Luo, Xing Niu, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 67-82
Closed Access | Times Cited: 4

The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2

Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets
Haixiao Jiang, Wei Zeng, Xiaoli Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 12

Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 9

Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
Yagang Song, Shuo Tian, Zhanzhan Li, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 59-76
Open Access | Times Cited: 1

Role of Fungi in Tumorigenesis: Promises and Challenges
Silvia Guglietta, Xin Li, Deepak Saxena
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 459-482
Closed Access | Times Cited: 1

Complex of intratumoral mycobiome and bacteriome predicts the recurrence of laryngeal squamous cell carcinoma
X. Mao, Huiying Huang, Limin Zhao, et al.
Applied and Environmental Microbiology (2025)
Open Access | Times Cited: 1

Global fungal-host interactome mapping identifies host targets of candidalysin
Tianyi Zhang, Yaoqi Chen, Jing-Cong Tan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8

Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 8

Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?
Jie Qiu, Yuancong Jiang, Nanwei Ye, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Into the era of mycobiome-driven cancer research
Weici Liu, Zheshun Pi, Ning‐Ning Liu, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 389-392
Open Access | Times Cited: 5

IL-1β mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer
Zhiyong Zhang, Ying Chen, Xinyi Pan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies
Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Inflammation mediated by gut microbiome alterations promotes lung cancer development and an immunosuppressed tumor microenvironment
Zahraa Rahal, Yuejiang Liu, Fuduan Peng, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 12, pp. 1736-1752
Closed Access | Times Cited: 5

The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions
Yu Fu, Jia Li, Wenyun Cai, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 4, pp. 1560-1591
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top